UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003884
Receipt number R000004674
Scientific Title Multicenter clinical trial of nutritional Management in Reduced-Intensity Stem Cell Transplantation from An Unrelated Donor (with or without A Liquid Diet Containing Digested-form Oligopeptide)
Date of disclosure of the study information 2010/07/07
Last modified on 2014/01/20 09:51:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter clinical trial of nutritional Management in Reduced-Intensity Stem Cell Transplantation from An Unrelated Donor (with or without A Liquid Diet Containing Digested-form Oligopeptide)

Acronym

NST-04

Scientific Title

Multicenter clinical trial of nutritional Management in Reduced-Intensity Stem Cell Transplantation from An Unrelated Donor (with or without A Liquid Diet Containing Digested-form Oligopeptide)

Scientific Title:Acronym

NST-04

Region

Japan


Condition

Condition

hematological malignancies

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and safety of oligopeptide in patients who underwent unrelated stem cell transplantation

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Probability of more than grade 3 intestinal toxicity up to 28 days after transplant

Key secondary outcomes

(1) 1-year overall survival and 1-year progression-free survival
(2) Total duration of more than grade 3 intestinal toxicity up to 28 days
(3) Treatment-related toxicity
(4) Engraftment
(5) Acute GVHD
(6) Infection
(7) Duration of TPN
(8) Dose and duration of intravenous molphine
(9) Total dose of insulin
(10) Hyperglycemia and hypoglycemia
(11) DAO activity
(12) Laboratory data (total protein, albumin, cholinesterase, pre-albumin, RBP, CRP, urinary creatinine)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Patients will take oligopeptide from the beginning of conditioning regimen and up to 21 days after transplantation

Interventions/Control_2

Patients in non-oligopeptide group will not take oligopeptide

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Patient with hematological malignancy which has the indication for the allogeneic transplant.
(2) Patient who receives an unrelated stem cell source
(3) Patient who can take oligopeptide
(4) Age from 18 to 70
(5) ECOG PS 0 or 1
(6) Patient who cannot tolerate myeloablative conditioning regimen
(7) Patient who had the informed consent
(8) Patient who expects to survive longer than 3 months

Key exclusion criteria

(1) Patient with severe organ dysfunction
(2) Patient with the postitivity of anti-HIV antibody
(3) Patient with uncontrolled infection
(4) Patient with pregnancy or breast feeding
(5) Patient with pshycological disease
(6) Patient with allergy against the drugs which are used for allogeneic transplant including chemotherapy and GVHD prophylaxis
(7) Patient with allergy against oligopeptide

Target sample size

76


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sung-Won Kim

Organization

National Cancer Center Hospital

Division name

Department of hematology

Zip code


Address

5-1-1, Tsukiji, Chuo-Ku, Tokyo

TEL

+81-3-3542-2511

Email

skim@ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Sung-Won Kim

Organization

National Cancer Center Hospital

Division name

Department of hematology

Zip code


Address

5-1-1, Tsukiji, Chuo-Ku, Tokyo

TEL

+81-3-3542-2511

Homepage URL


Email

skim@ncc.go.jp


Sponsor or person

Institute

Research supported by Ministry of Health, Labour and Welfare

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がんセンター中央病院


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2010 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date

2013 Year 06 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 07 Month 07 Day

Last modified on

2014 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004674


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name